Niki BioSolutions, Inc. (NIKI) Stock Ticker
Market factors today
Unlock the full NIKI picture
About Niki BioSolutions, Inc.
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
NIKI stock facts
| Ticker symbol | NIKI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $387,640 |
| CEO | Chung Yuen Huen |
| Employees | 1 |
| Headquarters | Princeton, NJ, US |
| IPO date | 2026-07-20 |
| Website | www.aptorumgroup.com |
What you can see for NIKI on Tickr
Live NIKI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NIKI report.
Rankings
FAQ
What is the ticker symbol for Niki BioSolutions, Inc.?
The ticker symbol for Niki BioSolutions, Inc. is NIKI, listed on the NASDAQ.
What is NIKI?
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based…